Skip to main content

Passage BIO, Inc.

PASG
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001787297

In the last 90 days, Passage BIO, Inc. insiders filed 1 open-market purchase and 0 sales; 29 institutions reported holding it in 13F filings for Q2 2026, worth $6.82M in total; no superinvestor holds it.

13F holders, Q4 2023

Institutional positions in Passage BIO, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
52
+1 vs. Q3 2023
Shares held
32.8M
+369.1K (+1.1%) vs. Q3 2023
Total value
$33.1M
+$11.8M (+55.2%) vs. Q3 2023
New holders
8
15 more added
Sold out
7
10 more reduced

Compare with Q3 2023: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting PASG on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2023: 52 institutions
Q1 2021: 90 institutionsQ2 2021: 102 institutionsQ3 2021: 103 institutionsQ4 2021: 102 institutionsQ1 2022: 110 institutionsQ2 2022: 87 institutionsQ3 2022: 76 institutionsQ4 2022: 68 institutionsQ1 2023: 59 institutionsQ2 2023: 56 institutionsQ3 2023: 51 institutionsQ4 2023: 52 institutionsQ1 2024: 51 institutionsQ2 2024: 45 institutionsQ3 2024: 45 institutionsQ4 2024: 46 institutionsQ1 2025: 42 institutionsQ2 2025: 41 institutionsQ3 2025: 32 institutionsQ4 2025: 30 institutionsQ1 2026: 35 institutionsQ2 2026: 29 institutions
Value heldQ4 2023: $33.1M
Q1 2021: $786.5MQ2 2021: $558.8MQ3 2021: $419.1MQ4 2021: $277.7MQ1 2022: $133.2MQ2 2022: $99.6MQ3 2022: $49.3MQ4 2022: $51.6MQ1 2023: $34.1MQ2 2023: $31.4MQ3 2023: $21.3MQ4 2023: $33.1MQ1 2024: $54.4MQ2 2024: $32.0MQ3 2024: $27.1MQ4 2024: $21.6MQ1 2025: $12.8MQ2 2025: $33.0MQ3 2025: $13.2MQ4 2025: $18.6MQ1 2026: $13.8MQ2 2026: $6.82M
Institutions holding PASG and their total value by quarter
QuarterHoldersValue
Q2 202629$6.82M
Q1 202635$13.8M
Q4 202530$18.6M
Q3 202532$13.2M
Q2 202541$33.0M
Q1 202542$12.8M
Q4 202446$21.6M
Q3 202445$27.1M
Q2 202445$32.0M
Q1 202451$54.4M
Q4 202352$33.1M
Q3 202351$21.3M
Q2 202356$31.4M
Q1 202359$34.1M
Q4 202268$51.6M
Q3 202276$49.3M
Q2 202287$99.6M
Q1 2022110$133.2M
Q4 2021102$277.7M
Q3 2021103$419.1M
Q2 2021102$558.8M
Q1 202190$786.5M

Institutions, Q4 2023

Shares, value and share of portfolio for each institution holding Passage BIO, Inc.; share changes are against Q3 2023.

Institutions holding PASG in Q4 2023
InstitutionSharesValue% of portfolioChange in sharesAction
OrbiMed Advisors LLC10,124,576$10.2M0.20%00.0%Unchanged
Versant Venture Management, LLC4,959,769$5.01M1.29%00.0%Unchanged
Erste Asset Management GmbH2,960,800$2.99M0.04%+600,000+25.4%Added
New Leaf Venture Partners, L.L.C.2,497,922$2.52M2.03%00.0%Unchanged
Tang Capital Management LLC2,400,000$2.42M0.22%+2,000,000+500.0%Added
Vanguard Group Inc2,018,882$2.04M0.00%+9990.0%Added
Renaissance Technologies LLC1,223,351$1.24M0.00%+228,952+23.0%Added
BlackRock Inc.1,022,563$1.03M0.00%+10,239+1.0%Added
Millennium Management LLC788,175$796.1K0.00%+671,759+577.0%Added
Acadian Asset Management LLC604,678$610.0K0.00%00.0%Unchanged
Pale Fire Capital SE581,257$587.1K0.09%+482,595+489.1%Added
Bridgeway Capital Management, LLC506,600$511.7K0.01%00.0%Unchanged
Acuitas Investments, LLC417,734$421.9K0.22%−427−0.1%Reduced
Lynx1 Capital Management LP379,159$383.0K0.15%+189,035+99.4%Added
Geode Capital Management, LLC332,203$335.6K0.00%00.0%Unchanged
Citadel Advisors LLC311,713$314.8K0.00%+208,214+201.2%Added
Weiss Multi-Strategy Advisers LLC242,900$245.0K0.01%−124,796−33.9%Reduced
Two Sigma Advisers, LP210,500$212.6K0.00%−29,700−12.4%Reduced
Two Sigma Investments, LP201,153$203.2K0.00%−27,101−11.9%Reduced
RBF Capital, LLC142,807$144.2K0.01%00.0%Unchanged
State Street Corp123,873$125.1K0.00%00.0%Unchanged
Fiduciary Trust Co115,000$116.2K0.00%00.0%Unchanged
Marquette Asset Management, LLC85,500$86.4K0.02%−550−0.6%Reduced
Northern Trust Corp76,885$77.7K0.00%+23,772+44.8%Added
Virtu Financial LLC67,704$68.0K0.01%+67,704New
DLK Investment Management, LLC64,000$64.6K0.03%+64,000New
FMR LLC62,021$62.6K0.00%00.0%Unchanged
Two Sigma Securities, LLC40,327$40.7K0.00%+40,327New
XTX Topco Ltd28,429$28.7K0.01%+7,005+32.7%Added
Goldman Sachs Group Inc26,896$27.2K0.00%−553−2.0%Reduced
Cresset Asset Management, LLC23,725$24.0K0.00%00.0%Unchanged
HighTower Advisors, LLC22,264$23.0K0.00%+1,829+9.0%Added
Scientech Research LLC18,853$19.0K0.02%+18,853New
Susquehanna International Group, LLP18,533$18.7K0.00%+18,533New
Morgan Stanley13,837$14.0K0.00%−163,083−92.2%Reduced
Bank of New York Mellon Corp13,647$13.8K0.00%00.0%Unchanged
Barclays PLC13,153$13.3K0.00%00.0%Unchanged
Federation des caisses Desjardins du Quebec5,010$5.06K0.00%−3,000−37.5%Reduced
Citigroup Inc4,798$4.85K0.00%+4,798New
Simplex Trading, LLC2,089$2.00K0.00%+2,089New
JPMorgan Chase & Co1,377$1.39K0.00%−8,008−85.3%Reduced
UBS Group AG1,059$1.07K0.00%+1,059New
Steward Partners Investment Advisory, LLC1,010$1.02K0.00%00.0%Unchanged
Rhumbline Advisers783$7900.00%00.0%Unchanged
Wells Fargo & Company304$3070.00%+16+5.6%Added
Advisor Group Holdings, Inc.217$2190.00%−59−21.4%Reduced
Group One Trading, L.P.47$470.00%00.0%Unchanged
Bank of America Corp32$320.00%+31+3,100.0%Added
Qube Research & Technologies Ltd4$40.00%00.0%Unchanged
TSFG, LLC100$00.00%00.0%Unchanged
Royal Bank of Canada379$00.00%+339+847.5%Added
CWM, LLC5$00.00%00.0%Unchanged
BML Capital Management, LLC0$00.00%−2,058,767−100.0%Sold out
Frazier Life Sciences Management, L.P.0$00.00%−1,758,219−100.0%Sold out
Squarepoint Ops LLC0$00.00%−74,046−100.0%Sold out
Tower Research Capital LLC (TRC)0$00.00%−13,725−100.0%Sold out
D. E. Shaw & Co., Inc.0$00.00%−10,026−100.0%Sold out
Federated Hermes, Inc.0$00.00%−511−100.0%Sold out
US Bancorp0$00.00%−500−100.0%Sold out